Gan & Lee and JW Pharmaceutical agree on bofanglutide commercialisation

​Gan & Lee Pharmaceuticals has entered an exclusive licence agreement with JW Pharmaceutical for the commercialisation of bofanglutide injection in South Korea.

The post Gan & Lee and JW Pharmaceutical agree on bofanglutide commercialisation appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.